Estrogen Receptor Antagonist [EPC]

Estrogen Receptor Antagonist [EPC] was reported 40549 times

These side effects are most commonly reported by patients taking drugs of the Estrogen Receptor Antagonist [EPC] class:

# Drug class Count
0 FATIGUE 5334
1 NAUSEA 4565
2 MALIGNANT NEOPLASM PROGRESSION 4502
3 DEATH 3297
4 DIARRHOEA 3231
5 NEUTROPENIA 2553
6 WHITE BLOOD CELL COUNT DECREASED 2299
7 VOMITING 2288
8 METASTASES TO BONE 2233
9 NEOPLASM PROGRESSION 2208
10 PAIN 2150
11 DISEASE PROGRESSION 2109
12 ASTHENIA 2056
13 DECREASED APPETITE 1855
14 METASTASES TO LIVER 1834
15 DYSPNOEA 1784
16 ARTHRALGIA 1781
17 DRUG INEFFECTIVE 1727
18 BREAST CANCER METASTATIC 1706
19 ALOPECIA 1503
20 RASH 1414
21 MALAISE 1409
22 OFF LABEL USE 1409
23 HEADACHE 1374
24 ANAEMIA 1370
25 CONSTIPATION 1334
26 COUGH 1286
27 DIZZINESS 1265
28 BACK PAIN 1260
29 WEIGHT DECREASED 1205
30 PYREXIA 1162
31 PAIN IN EXTREMITY 1113
32 BREAST CANCER 965
33 PRURITUS 947
34 TUMOUR MARKER INCREASED 900
35 PLATELET COUNT DECREASED 897
36 THROMBOCYTOPENIA 867
37 BONE PAIN 858
38 NEUTROPHIL COUNT DECREASED 851
39 PLEURAL EFFUSION 816
40 HAEMOGLOBIN DECREASED 813
41 METASTASES TO LUNG 805
42 ABDOMINAL DISCOMFORT 758
43 LEUKOPENIA 745
44 GENERAL PHYSICAL HEALTH DETERIORATION 737
45 HYPERGLYCAEMIA 734
46 HOT FLUSH 732
47 ABDOMINAL PAIN UPPER 724
48 ABDOMINAL PAIN 719
49 OSTEONECROSIS OF JAW 700
50 NEUROPATHY PERIPHERAL 686
51 PNEUMONIA 684
52 STOMATITIS 677
53 PRODUCT DOSE OMISSION ISSUE 667
54 GAIT DISTURBANCE 656
55 MYALGIA 639
56 URINARY TRACT INFECTION 625
57 FALL 623
58 INSOMNIA 623
59 DEHYDRATION 597
60 ANXIETY 590
61 COVID-19 582
62 DYSPEPSIA 582
63 FEELING ABNORMAL 582
64 RED BLOOD CELL COUNT DECREASED 570
65 HYPERTENSION 558
66 DRUG INTOLERANCE 557
67 DRY SKIN 545
68 PERIPHERAL SWELLING 536
69 INJECTION SITE PAIN 497
70 HYPOAESTHESIA 493
71 ILLNESS 489
72 BLOOD GLUCOSE INCREASED 487
73 WEIGHT INCREASED 480
74 MUSCLE SPASMS 478
75 METASTASES TO LYMPH NODES 472
76 NASOPHARYNGITIS 470
77 CHEST PAIN 468
78 ERYTHEMA 455
79 ASCITES 453
80 DEPRESSION 441
81 HYPERSENSITIVITY 439
82 DECREASED IMMUNE RESPONSIVENESS 426
83 OEDEMA PERIPHERAL 418
84 BLOOD CREATININE INCREASED 417
85 PRODUCT USE ISSUE 417
86 CONDITION AGGRAVATED 411
87 METASTASES TO CENTRAL NERVOUS SYSTEM 406
88 SOMNOLENCE 404
89 DYSPHAGIA 401
90 CHILLS 397
91 MYELOSUPPRESSION 396
92 PARAESTHESIA 396
93 INFECTION 395
94 PULMONARY EMBOLISM 392
95 ASPARTATE AMINOTRANSFERASE INCREASED 389
96 MEMORY IMPAIRMENT 375
97 METASTASIS 375
98 FULL BLOOD COUNT DECREASED 357
99 GASTROOESOPHAGEAL REFLUX DISEASE 357
100 ALANINE AMINOTRANSFERASE INCREASED 354
101 EPISTAXIS 349
102 ABDOMINAL DISTENSION 348
103 LYMPHADENOPATHY 348
104 METASTASES TO SPINE 330
105 RENAL IMPAIRMENT 327
106 ACUTE KIDNEY INJURY 321
107 OROPHARYNGEAL PAIN 320
108 INTERSTITIAL LUNG DISEASE 315
109 DRY MOUTH 314
110 BREAST CANCER RECURRENT 313
111 MUSCULAR WEAKNESS 303
112 VISUAL IMPAIRMENT 302
113 MUCOSAL INFLAMMATION 300
114 DYSGEUSIA 299
115 PANCYTOPENIA 294
116 RENAL FAILURE 287
117 CONFUSIONAL STATE 285
118 INFLUENZA 282
119 BLOOD PRESSURE INCREASED 280
120 CONTUSION 278
121 MUSCULOSKELETAL PAIN 277
122 DIABETES MELLITUS 275
123 HEPATIC ENZYME INCREASED 274
124 LIVER DISORDER 274
125 PRODUCT USE IN UNAPPROVED INDICATION 273
126 BONE LESION 271
127 HEPATIC FAILURE 271
128 PNEUMONITIS 267
129 CARBOHYDRATE ANTIGEN 15-3 INCREASED 264
130 BONE DISORDER 262
131 DYSPNOEA EXERTIONAL 260
132 HYPOTENSION 257
133 SWELLING 251
134 THROMBOSIS 249
135 TOXICITY TO VARIOUS AGENTS 249
136 ORAL PAIN 246
137 SLEEP DISORDER 244
138 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 241
139 URTICARIA 241
140 VISION BLURRED 241
141 NEOPLASM MALIGNANT 240
142 PAIN IN JAW 240
143 SEPSIS 238
144 DISCOMFORT 237
145 PULMONARY MASS 237
146 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 234
147 SKIN EXFOLIATION 234
148 MUSCULOSKELETAL CHEST PAIN 222
149 SECOND PRIMARY MALIGNANCY 221
150 TREATMENT FAILURE 221
151 BLOOD CHOLESTEROL INCREASED 220
152 CHEST DISCOMFORT 220
153 DYSPHONIA 220
154 HYPERHIDROSIS 216
155 OSTEONECROSIS 216
156 ATRIAL FIBRILLATION 215
157 PULMONARY OEDEMA 214
158 HEPATOTOXICITY 211
159 SINUSITIS 208
160 PRODUCT DOSE OMISSION IN ERROR 206
161 BLOOD ALKALINE PHOSPHATASE INCREASED 204
162 TREMOR 204
163 DEPRESSED MOOD 203
164 CEREBROVASCULAR ACCIDENT 202
165 CELLULITIS 200
166 DRUG HYPERSENSITIVITY 199
167 HEPATIC FUNCTION ABNORMAL 199
168 LABORATORY TEST ABNORMAL 197
169 BLOOD BILIRUBIN INCREASED 195
170 CARDIAC FAILURE 195
171 DRUG INTERACTION 195
172 HAEMATOCRIT DECREASED 195
173 LUNG DISORDER 194
174 SYNCOPE 193
175 HEPATIC LESION 192
176 LACRIMATION INCREASED 192
177 ELECTROCARDIOGRAM QT PROLONGED 189
178 FULL BLOOD COUNT ABNORMAL 189
179 LYMPHOEDEMA 189
180 BURNING SENSATION 188
181 BONE MARROW FAILURE 187
182 FLATULENCE 187
183 INFLAMMATION 187
184 LIVER FUNCTION TEST INCREASED 186
185 HYPOKALAEMIA 185
186 SPINAL PAIN 185
187 TRANSAMINASES INCREASED 185
188 TASTE DISORDER 182
189 ARTHRITIS 179
190 IMPAIRED HEALING 179
191 POLYNEUROPATHY 179
192 GASTROINTESTINAL DISORDER 174
193 NECK PAIN 174
194 BALANCE DISORDER 173
195 METASTASES TO PLEURA 173
196 RESPIRATORY FAILURE 172
197 TACHYCARDIA 171
198 BLOOD COUNT ABNORMAL 170
199 PRODUCTIVE COUGH 170
200 HAEMORRHAGE 169
201 DRY EYE 168
202 EATING DISORDER 168
203 PIK3CA-ACTIVATED MUTATION 167
204 FEEDING DISORDER 166
205 INFLUENZA LIKE ILLNESS 166
206 JOINT SWELLING 166
207 TOOTHACHE 166
208 GAMMA-GLUTAMYLTRANSFERASE INCREASED 165
209 OEDEMA 164
210 CATARACT 163
211 METASTASES TO SKIN 163
212 PALPITATIONS 163
213 RASH PRURITIC 163
214 DEEP VEIN THROMBOSIS 162
215 HEART RATE INCREASED 162
216 FEELING COLD 161
217 GASTRITIS 161
218 MOBILITY DECREASED 160
219 BRONCHITIS 159
220 OSTEOARTHRITIS 159
221 STRESS 159
222 HOSPITALISATION 157
223 JAUNDICE 156
224 OSTEOMYELITIS 155
225 OSTEOPOROSIS 155
226 SWELLING FACE 155
227 C-REACTIVE PROTEIN INCREASED 153
228 FEBRILE NEUTROPENIA 153
229 THROAT IRRITATION 153
230 ADVERSE DRUG REACTION 152
231 METASTASES TO PERITONEUM 148
232 SKIN DISCOLOURATION 148
233 FEELING HOT 147
234 MIGRAINE 147
235 SKIN DISORDER 147
236 LOSS OF CONSCIOUSNESS 146
237 NEOPLASM 146
238 NERVOUSNESS 145
239 RHINORRHOEA 144
240 CARCINOEMBRYONIC ANTIGEN INCREASED 141
241 LIMB DISCOMFORT 141
242 INJECTION SITE MASS 140
243 MOVEMENT DISORDER 138
244 THERAPY CESSATION 137
245 TOOTH DISORDER 136
246 BLISTER 135
247 SKIN LESION 134
248 HORMONE RECEPTOR POSITIVE HER2 NEGATIVE BREAST CANCER 133
249 GAIT INABILITY 132
250 HAEMATOTOXICITY 132
251 HEPATIC STEATOSIS 132
252 CYSTITIS 131
253 DRUG RESISTANCE 131
254 HERPES ZOSTER 131
255 INVASIVE DUCTAL BREAST CARCINOMA 131
256 MUSCULOSKELETAL STIFFNESS 131
257 AGEUSIA 130
258 VERTIGO 130
259 SCIATICA 128
260 ARRHYTHMIA 127
261 DYSURIA 127
262 MYOCARDIAL INFARCTION 127
263 BLOOD PRESSURE DECREASED 126
264 PRODUCT USE COMPLAINT 126
265 ILL-DEFINED DISORDER 125
266 SEIZURE 125
267 BLOOD POTASSIUM DECREASED 124
268 NAIL DISORDER 124
269 BLOOD TEST ABNORMAL 123
270 UPPER RESPIRATORY TRACT INFECTION 123
271 WHITE BLOOD CELL COUNT INCREASED 122
272 WOUND 122
273 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 121
274 HYPONATRAEMIA 120
275 NASAL CONGESTION 120
276 WHITE BLOOD CELL COUNT ABNORMAL 120
277 INJURY 118
278 POLLAKIURIA 118
279 BREAST PAIN 117
280 EJECTION FRACTION DECREASED 117
281 ONYCHOCLASIS 117
282 RIB FRACTURE 117
283 PATHOLOGICAL FRACTURE 115
284 HEPATIC CIRRHOSIS 114
285 MOUTH ULCERATION 114
286 CARDIAC DISORDER 113
287 OSTEOLYSIS 113
288 RENAL DISORDER 113
289 CANCER PAIN 112
290 PERICARDIAL EFFUSION 112
291 DRUG DOSE OMISSION 111
292 NEURALGIA 111
293 THERAPY PARTIAL RESPONDER 111
294 FLUID RETENTION 110
295 FLUSHING 110
296 INCORRECT DOSE ADMINISTERED 110
297 LIVER INJURY 110
298 SPEECH DISORDER 110
299 CANDIDA INFECTION 108
300 CHOLELITHIASIS 108
301 HEPATITIS 108
302 SKIN FISSURES 107
303 CYTOPENIA 106
304 SKIN TOXICITY 106
305 DIABETIC KETOACIDOSIS 105
306 ERYTHEMA MULTIFORME 105
307 HOSPICE CARE 104
308 LIVER FUNCTION TEST ABNORMAL 104
309 GLOMERULAR FILTRATION RATE DECREASED 103
310 DISEASE RECURRENCE 102
311 FEMUR FRACTURE 102
312 HAEMATOMA 102
313 HAEMORRHOIDS 102
314 NIGHT SWEATS 102
315 AMNESIA 101
316 MASS 101
317 NODULE 101
318 BODY HEIGHT DECREASED 100
319 IMMUNODEFICIENCY 99
320 LYMPHOCYTE COUNT DECREASED 99
321 HYPOACUSIS 98
322 HYPOGLYCAEMIA 98
323 INTENTIONAL PRODUCT MISUSE 98
324 RETCHING 98
325 COLITIS 97
326 ECZEMA 97
327 FOREIGN BODY IN THROAT 97
328 HIP FRACTURE 97
329 RED CELL DISTRIBUTION WIDTH INCREASED 97
330 DRUG-INDUCED LIVER INJURY 96
331 DYSSTASIA 96
332 LETHARGY 96
333 OSTEOPENIA 96
334 PRODUCT DOSE OMISSION 95
335 SPINAL OSTEOARTHRITIS 95
336 DENTAL CARIES 94
337 MUSCULOSKELETAL DISCOMFORT 94
338 RESTLESSNESS 94
339 TOOTH EXTRACTION 94
340 BRAIN OEDEMA 93
341 OSTEOSCLEROSIS 92
342 OXYGEN SATURATION DECREASED 91
343 URINARY RETENTION 91
344 ATELECTASIS 90
345 HEPATOMEGALY 90
346 ARTHROPATHY 89
347 BONE CANCER 89
348 CARDIAC FAILURE CONGESTIVE 88
349 HYPOTHYROIDISM 88
350 INTERVERTEBRAL DISC PROTRUSION 88
351 MALIGNANT PLEURAL EFFUSION 88
352 METASTATIC NEOPLASM 88
353 BLOOD CALCIUM DECREASED 87
354 BREAST MASS 87
355 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 87
356 NO ADVERSE EVENT 87
357 HYPERSOMNIA 86
358 JOINT STIFFNESS 86
359 CHOKING 85
360 HYPOCALCAEMIA 85
361 OESOPHAGITIS 85
362 SKIN ULCER 85
363 ADVERSE EVENT 84
364 HAEMOGLOBIN ABNORMAL 84
365 HYPERCALCAEMIA 84
366 MEAN CELL VOLUME INCREASED 84
367 APHTHOUS ULCER 83
368 BLOOD GLUCOSE ABNORMAL 83
369 BREAST CANCER FEMALE 83
370 DERMATITIS 83
371 HEAD INJURY 83
372 INJECTION SITE SWELLING 83
373 HIATUS HERNIA 82
374 HYDRONEPHROSIS 82
375 FRACTURE 81
376 GINGIVAL PAIN 81
377 INTESTINAL OBSTRUCTION 81
378 RASH MACULAR 81
379 TOOTH FRACTURE 81
380 ASTHMA 80
381 BLOOD CREATININE ABNORMAL 80
382 BLOOD UREA INCREASED 80
383 HYPOXIA 80
384 ANAPHYLACTIC REACTION 79
385 PSEUDOCIRRHOSIS 79
386 BLOOD LACTATE DEHYDROGENASE INCREASED 78
387 BLOOD SODIUM DECREASED 78
388 HEPATIC CYST 78
389 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 78
390 THERAPY NON-RESPONDER 78
391 VIRAL INFECTION 78
392 EAR PAIN 77
393 HYPOPHAGIA 77
394 INJECTION SITE BRUISING 77
395 INJECTION SITE ERYTHEMA 77
396 RASH ERYTHEMATOUS 77
397 RHABDOMYOLYSIS 77
398 UNDERDOSE 77
399 URINE ODOUR ABNORMAL 77
400 RECTAL HAEMORRHAGE 76
401 URINARY INCONTINENCE 76
402 ACNE 75
403 CARDIAC ARREST 75
404 CONCOMITANT DISEASE AGGRAVATED 75
405 PRODUCT SIZE ISSUE 75
406 OVARIAN CANCER 74
407 WHEEZING 74
408 LOCALISED INFECTION 73
409 MULTIPLE ORGAN DYSFUNCTION SYNDROME 73
410 TOOTH INFECTION 73
411 CARDIOMEGALY 72
412 CRYING 72
413 HAEMATOCHEZIA 72
414 MADAROSIS 72
415 THERAPY INTERRUPTED 72
416 MEAN CELL HAEMOGLOBIN INCREASED 71
417 NEOPLASM RECURRENCE 71
418 PRODUCT AVAILABILITY ISSUE 71
419 SEPTIC SHOCK 71
420 SPINAL FRACTURE 71
421 DIVERTICULITIS 70
422 EMOTIONAL DISORDER 70
423 FUNGAL INFECTION 70
424 JAW DISORDER 69
425 MENTAL DISORDER 69
426 SENSORY DISTURBANCE 69
427 EMOTIONAL DISTRESS 68
428 GASTRIC DISORDER 68
429 GASTROINTESTINAL HAEMORRHAGE 68
430 HAIR TEXTURE ABNORMAL 68
431 LIMB INJURY 68
432 PELVIC PAIN 68
433 TOOTH ABSCESS 68
434 TOOTH LOSS 68
435 BLOOD CALCIUM INCREASED 67
436 CHROMATURIA 67
437 MITRAL VALVE INCOMPETENCE 67
438 NEUTROPHIL COUNT ABNORMAL 67
439 ORAL DISORDER 67
440 BLOOD POTASSIUM INCREASED 66
441 PLATELET COUNT ABNORMAL 66
442 SCAR 66
443 THIRST 66
444 EXPOSED BONE IN JAW 65
445 HEAD DISCOMFORT 65
446 NEPHROLITHIASIS 65
447 PARONYCHIA 65
448 BLOOD PRESSURE ABNORMAL 64
449 LYMPHADENOPATHY MEDIASTINAL 64
450 METASTASES TO PELVIS 64
451 TUMOUR MARKER ABNORMAL 64
452 AGITATION 63
453 CENTRAL NERVOUS SYSTEM LESION 63
454 COGNITIVE DISORDER 63
455 GLOSSODYNIA 63
456 HYPERTRANSAMINASAEMIA 63
457 LUNG INFILTRATION 63
458 LUNG NEOPLASM MALIGNANT 63
459 TRICUSPID VALVE INCOMPETENCE 63
460 CONJUNCTIVITIS 62
461 GINGIVITIS 62
462 INTENTIONAL PRODUCT USE ISSUE 62
463 PAROSMIA 62
464 THROAT TIGHTNESS 62
465 VARICOSE VEIN 62
466 VULVOVAGINAL DRYNESS 62
467 FLANK PAIN 61
468 GINGIVAL BLEEDING 61
469 INJECTION SITE PRURITUS 61
470 LOWER RESPIRATORY TRACT INFECTION 61
471 PLATELET COUNT INCREASED 61
472 RESPIRATORY DISORDER 61
473 ROAD TRAFFIC ACCIDENT 61
474 THERAPEUTIC RESPONSE UNEXPECTED 61
475 UNEVALUABLE EVENT 61
476 BLOOD PRESSURE SYSTOLIC INCREASED 60
477 DELIRIUM 60
478 GLYCOSYLATED HAEMOGLOBIN INCREASED 60
479 HYPERLIPIDAEMIA 60
480 LIP SWELLING 60
481 PAIN OF SKIN 60
482 RENAL CYST 60
483 COMA 59
484 INCREASED APPETITE 59
485 ABDOMINAL PAIN LOWER 58
486 BLOOD TRIGLYCERIDES INCREASED 58
487 BRAIN FOG 58
488 GASTROENTERITIS VIRAL 58
489 INJECTION SITE REACTION 58
490 INTERVERTEBRAL DISC DEGENERATION 58
491 MOOD SWINGS 58
492 OROPHARYNGEAL DISCOMFORT 58
493 PIGMENTATION DISORDER 58
494 SKIN BURNING SENSATION 58
495 SKIN MASS 58
496 SPINAL COMPRESSION FRACTURE 58
497 STREPTOCOCCAL SEPSIS 58
498 TYPE 2 DIABETES MELLITUS 58
499 VEIN DISORDER 58
500 HYPERKALAEMIA 57
501 IRRITABILITY 57
502 METASTASES TO MENINGES 57
503 PNEUMOTHORAX 57
504 POOR QUALITY SLEEP 57
505 POSITRON EMISSION TOMOGRAM ABNORMAL 57
506 PRESYNCOPE 57
507 SPINAL DISORDER 57
508 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 57
509 TINNITUS 57
510 ULCER 57
511 VAGINAL HAEMORRHAGE 57
512 DEMENTIA 56
513 DISTURBANCE IN ATTENTION 56
514 EYE SWELLING 56
515 FREQUENT BOWEL MOVEMENTS 56
516 HALLUCINATION 56
517 MUSCLE ATROPHY 56
518 NASAL DRYNESS 56
519 ORAL HERPES 56
520 DIPLOPIA 55
521 DISORIENTATION 55
522 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 55
523 ERUCTATION 55
524 HYPOAESTHESIA ORAL 55
525 LACTIC ACIDOSIS 55
526 ORAL DISCOMFORT 55
527 ERYSIPELAS 54
528 HEPATIC MASS 54
529 HEPATIC NEOPLASM 54
530 INJECTION SITE NECROSIS 54
531 RECURRENT CANCER 54
532 TENDERNESS 54
533 THERAPEUTIC RESPONSE DECREASED 54
534 VASCULAR DEVICE INFECTION 54
535 BLOOD CREATININE DECREASED 53
536 CACHEXIA 53
537 CARBOHYDRATE ANTIGEN 27.29 INCREASED 53
538 DEAFNESS 53
539 EYE DISORDER 53
540 EYE PRURITUS 53
541 IMMUNOSUPPRESSION 53
542 PSEUDOMONAL SEPSIS 53
543 RASH MACULO-PAPULAR 53
544 VITAMIN D DEFICIENCY 53
545 INCONTINENCE 52
546 MOOD ALTERED 52
547 SKIN IRRITATION 52
548 BLOOD BILIRUBIN ABNORMAL 51
549 EYE PAIN 51
550 GINGIVAL SWELLING 51
551 IMMUNE SYSTEM DISORDER 51
552 NEUTROPHIL COUNT INCREASED 51
553 RHINITIS 51
554 APHONIA 50
555 BLOOD GLUCOSE DECREASED 50
556 BREAST CANCER STAGE IV 50
557 BRONCHOSPASM 50
558 GENE MUTATION 50
559 NERVE INJURY 50
560 PORTAL HYPERTENSION 50
561 PULMONARY HYPERTENSION 50
562 BONE LOSS 49
563 CHRONIC KIDNEY DISEASE 49
564 HAEMATEMESIS 49
565 HEPATIC CANCER 49
566 HYPERTENSIVE CRISIS 49
567 ISCHAEMIC STROKE 49
568 SKIN REACTION 49
569 ABSCESS 48
570 DERMATITIS ALLERGIC 48
571 EXOSTOSIS 48
572 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 48
573 MENTAL STATUS CHANGES 48
574 OCULAR HYPERAEMIA 48
575 PALLOR 48
576 PANCREATITIS ACUTE 48
577 PULMONARY FIBROSIS 48
578 APPETITE DISORDER 47
579 BACTERIAL INFECTION 47
580 GROIN PAIN 47
581 INTENTIONAL DOSE OMISSION 47
582 MALNUTRITION 47
583 METASTASES TO THORAX 47
584 NASAL MUCOSAL DISORDER 47
585 ODYNOPHAGIA 47
586 PHARYNGITIS 47
587 PRIMARY SEQUESTRUM 47
588 PRODUCT PRESCRIBING ERROR 47
589 RESPIRATORY TRACT INFECTION 47
590 SPINAL CORD COMPRESSION 47
591 ACUTE HEPATIC FAILURE 46
592 ACUTE RESPIRATORY FAILURE 46
593 AORTIC ARTERIOSCLEROSIS 46
594 FISTULA 46
595 GASTROINTESTINAL TOXICITY 46
596 HAIR GROWTH ABNORMAL 46
597 HYPOALBUMINAEMIA 46
598 JOINT INJURY 46
599 METASTASES TO CHEST WALL 46
600 MOUTH SWELLING 46
601 VITAMIN D DECREASED 46
602 CARDIOTOXICITY 45
603 CEREBRAL INFARCTION 45
604 CHOLESTASIS 45
605 EYE IRRITATION 45
606 GRANULOCYTOPENIA 45
607 HEART RATE DECREASED 45
608 HYPOKINESIA 45
609 ALANINE AMINOTRANSFERASE ABNORMAL 44
610 CARDIOMYOPATHY 44
611 DRUG ERUPTION 44
612 DYSARTHRIA 44
613 OVERDOSE 44
614 PULMONARY CONGESTION 44
615 PULMONARY THROMBOSIS 44
616 SCOLIOSIS 44
617 ANGINA PECTORIS 43
618 BODY TEMPERATURE INCREASED 43
619 GASTRIC ULCER 43
620 GASTROINTESTINAL PAIN 43
621 METASTASES TO BREAST 43
622 SMALL INTESTINAL OBSTRUCTION 43
623 STAPHYLOCOCCAL INFECTION 43
624 TRANSIENT ISCHAEMIC ATTACK 43
625 UPPER LIMB FRACTURE 43
626 WHITE BLOOD CELL DISORDER 43
627 BLOOD CALCIUM ABNORMAL 42
628 BLOOD MAGNESIUM DECREASED 42
629 DIVERTICULUM INTESTINAL 42
630 DRY THROAT 42
631 FEAR 42
632 ILEUS 42
633 INVASIVE LOBULAR BREAST CARCINOMA 42
634 LOOSE TOOTH 42
635 SINUS DISORDER 42
636 CARPAL TUNNEL SYNDROME 41
637 DISCOURAGEMENT 41
638 EMBOLISM 41
639 KIDNEY INFECTION 41
640 LIP DRY 41
641 METASTASES TO ADRENALS 41
642 PANIC ATTACK 41
643 RADICULOPATHY 41
644 THYROID DISORDER 41
645 APHASIA 40
646 BLINDNESS 40
647 BLOOD ALBUMIN DECREASED 40
648 BRAIN NEOPLASM 40
649 ELECTROLYTE IMBALANCE 40
650 INJECTION SITE NODULE 40
651 LYMPHOPENIA 40
652 METASTASES TO THE MEDIASTINUM 40
653 PERIPHERAL COLDNESS 40
654 POOR VENOUS ACCESS 40
655 SWOLLEN TONGUE 40
656 ARTERIOSCLEROSIS 39
657 BONE MARROW DISORDER 39
658 CHOLECYSTITIS 39
659 DECREASED INTEREST 39
660 HEPATIC ENZYME ABNORMAL 39
661 HEPATIC PAIN 39
662 HEPATOCELLULAR INJURY 39
663 LYMPHANGIOSIS CARCINOMATOSA 39
664 METASTASES TO EYE 39
665 NAIL BED INFLAMMATION 39
666 NEUROTOXICITY 39
667 PARALYSIS 39
668 RENAL PAIN 39
669 ANHEDONIA 38
670 ANISOCYTOSIS 38
671 BODY TEMPERATURE DECREASED 38
672 BURSITIS 38
673 COMPRESSION FRACTURE 38
674 HAIR COLOUR CHANGES 38
675 HYPERCHOLESTEROLAEMIA 38
676 LOWER LIMB FRACTURE 38
677 ORAL MUCOSAL BLISTERING 38
678 PULMONARY TOXICITY 38
679 PURULENT DISCHARGE 38
680 RETINAL DETACHMENT 38
681 SKELETAL INJURY 38
682 SKIN ATROPHY 38
683 ADENOCARCINOMA 37
684 ARTERIOSCLEROSIS CORONARY ARTERY 37
685 COAGULOPATHY 37
686 DECREASED ACTIVITY 37
687 FAECES DISCOLOURED 37
688 GLAUCOMA 37
689 HYPERBILIRUBINAEMIA 37
690 PELVIC FRACTURE 37
691 PORTAL VEIN THROMBOSIS 37
692 RESPIRATORY DISTRESS 37
693 SCRATCH 37
694 SECRETION DISCHARGE 37
695 SENSORY LOSS 37
696 BLOOD IRON DECREASED 36
697 DECUBITUS ULCER 36
698 EPILEPSY 36
699 FACIAL PAIN 36
700 GALLBLADDER DISORDER 36
701 HAEMOPTYSIS 36
702 HEPATIC CYTOLYSIS 36
703 HILAR LYMPHADENOPATHY 36
704 INJECTION SITE HAEMORRHAGE 36
705 MEDICATION ERROR 36
706 METASTASES TO BONE MARROW 36
707 PARAESTHESIA ORAL 36
708 PERIODONTITIS 36
709 RESTLESS LEGS SYNDROME 36
710 RHEUMATOID ARTHRITIS 36
711 ADNEXA UTERI MASS 35
712 CARBOHYDRATE ANTIGEN 125 INCREASED 35
713 FOOT FRACTURE 35
714 GOITRE 35
715 GOUT 35
716 INJECTION SITE DISCOMFORT 35
717 INTESTINAL METASTASIS 35
718 JOINT EFFUSION 35
719 METABOLIC ACIDOSIS 35
720 MUSCLE STRAIN 35
721 PETECHIAE 35
722 PRODUCT DISPENSING ERROR 35
723 PRODUCT SUPPLY ISSUE 35
724 SCAN ABNORMAL 35
725 SNEEZING 35
726 VERTEBRAL FORAMINAL STENOSIS 35
727 BLOOD URIC ACID INCREASED 34
728 DEVICE RELATED INFECTION 34
729 HEPATIC ENCEPHALOPATHY 34
730 HYPOMAGNESAEMIA 34
731 METASTASES TO SPINAL CORD 34
732 PLEURAL THICKENING 34
733 PROTEIN TOTAL INCREASED 34
734 RASH PAPULAR 34
735 STEVENS-JOHNSON SYNDROME 34
736 SURGERY 34
737 TENDONITIS 34
738 VISUAL ACUITY REDUCED 34
739 ABDOMINAL LYMPHADENOPATHY 33
740 BONE CANCER METASTATIC 33
741 CORONARY ARTERY DISEASE 33
742 FAECES SOFT 33
743 GASTROENTERITIS 33
744 HAIR DISORDER 33
745 MUCOSAL DRYNESS 33
746 PHLEBITIS 33
747 PROTEIN TOTAL DECREASED 33
748 SENSITIVE SKIN 33
749 BONE MARROW INFILTRATION 32
750 BONE NEOPLASM 32
751 BRADYCARDIA 32
752 CEREBRAL HAEMORRHAGE 32
753 CLOSTRIDIUM DIFFICILE INFECTION 32
754 HAEMATURIA 32
755 LIGAMENT SPRAIN 32
756 MYELODYSPLASTIC SYNDROME 32
757 ORAL INFECTION 32
758 POLYURIA 32
759 PROCEDURAL PAIN 32
760 PYELONEPHRITIS 32
761 RED BLOOD CELL SEDIMENTATION RATE INCREASED 32
762 RHINITIS ALLERGIC 32
763 SINUS TACHYCARDIA 32
764 SKIN HAEMORRHAGE 32
765 TUMOUR PAIN 32
766 VITILIGO 32
767 ACQUIRED GENE MUTATION 31
768 AGRANULOCYTOSIS 31
769 BLOOD ALBUMIN ABNORMAL 31
770 BLOOD THYROID STIMULATING HORMONE INCREASED 31
771 BREAST SWELLING 31
772 CIRCULATORY COLLAPSE 31
773 FEMORAL NECK FRACTURE 31
774 HEMIPARESIS 31
775 LARYNGITIS 31
776 MEAN CELL HAEMOGLOBIN DECREASED 31
777 MONOCYTE COUNT INCREASED 31
778 MUSCLE TIGHTNESS 31
779 OBESITY 31
780 OVERWEIGHT 31
781 PERIPHERAL SENSORY NEUROPATHY 31
782 PLEURAL FIBROSIS 31
783 PNEUMOCYSTIS JIROVECII PNEUMONIA 31
784 SPINAL COLUMN STENOSIS 31
785 STRESS CARDIOMYOPATHY 31
786 SYNOVIAL CYST 31
787 UPPER-AIRWAY COUGH SYNDROME 31
788 ACUTE MYOCARDIAL INFARCTION 30
789 ANAPHYLACTIC SHOCK 30
790 ASPARTATE AMINOTRANSFERASE ABNORMAL 30
791 ASPIRATION 30
792 BACK DISORDER 30
793 BLOOD URINE PRESENT 30
794 DEPRESSED LEVEL OF CONSCIOUSNESS 30
795 FRACTURED SACRUM 30
796 GINGIVAL DISORDER 30
797 HEART RATE IRREGULAR 30
798 HORMONE LEVEL ABNORMAL 30
799 INVASIVE BREAST CARCINOMA 30
800 LEFT VENTRICULAR DYSFUNCTION 30
801 LOCAL SWELLING 30
802 MONOCYTE COUNT DECREASED 30
803 OSTEITIS 30
804 PHOTOPHOBIA 30
805 ROTATOR CUFF SYNDROME 30
806 TONGUE DISORDER 30
807 BLOOD DISORDER 29
808 BLOOD PRESSURE FLUCTUATION 29
809 CLAVICLE FRACTURE 29
810 COORDINATION ABNORMAL 29
811 DEFORMITY 29
812 ECCHYMOSIS 29
813 HYPERMETABOLISM 29
814 MACROCYTOSIS 29
815 METASTASES TO OVARY 29
816 NECROSIS 29
817 NOCTURIA 29
818 PLEURAL NEOPLASM 29
819 PSORIASIS 29
820 RASH GENERALISED 29
821 SKIN LACERATION 29
822 SUICIDAL IDEATION 29
823 YELLOW SKIN 29
824 ABNORMAL FAECES 28
825 ANAL INCONTINENCE 28
826 BODY MASS INDEX INCREASED 28
827 BOWEL MOVEMENT IRREGULARITY 28
828 BREAST DISORDER 28
829 BRONCHIECTASIS 28
830 CYST 28
831 DIVERTICULUM 28
832 EMPHYSEMA 28
833 FACE OEDEMA 28
834 GENERAL PHYSICAL CONDITION ABNORMAL 28
835 MALIGNANT ASCITES 28
836 MICTURITION URGENCY 28
837 ORAL CANDIDIASIS 28
838 PRODUCT STORAGE ERROR 28
839 SKIN CANCER 28
840 SLEEP APNOEA SYNDROME 28
841 SUPRAVENTRICULAR TACHYCARDIA 28
842 TUMOUR MARKER DECREASED 28
843 VAGINAL DISCHARGE 28
844 VOCAL CORD PARALYSIS 28
845 ALTERED STATE OF CONSCIOUSNESS 27
846 BILE DUCT STENOSIS 27
847 CEREBRAL ISCHAEMIA 27
848 CHEST WALL MASS 27
849 DIASTOLIC DYSFUNCTION 27
850 DISSEMINATED INTRAVASCULAR COAGULATION 27
851 EXCESSIVE GRANULATION TISSUE 27
852 HORMONE RECEPTOR POSITIVE BREAST CANCER 27
853 INTERVERTEBRAL DISC SPACE NARROWING 27
854 IRON DEFICIENCY ANAEMIA 27
855 MASTICATION DISORDER 27
856 MENTAL IMPAIRMENT 27
857 MUSCLE DISORDER 27
858 MYOCARDITIS 27
859 OVARIAN CYST 27
860 PRODUCT QUALITY ISSUE 27
861 SCAB 27
862 SUPERINFECTION 27
863 THERAPEUTIC PRODUCT EFFECT DECREASED 27
864 THROMBOTIC MICROANGIOPATHY 27
865 TUBULOINTERSTITIAL NEPHRITIS 27
866 UTERINE LEIOMYOMA 27
867 ANGIOEDEMA 26
868 ANOSMIA 26
869 ASPHYXIA 26
870 BLOOD PRESSURE DIASTOLIC DECREASED 26
871 COLITIS ULCERATIVE 26
872 DILATED CARDIOMYOPATHY 26
873 DIZZINESS POSTURAL 26
874 ELLIPTOCYTOSIS 26
875 FAECALOMA 26
876 GLOSSITIS 26
877 HAEMANGIOMA 26
878 HUNGER 26
879 HYPERAESTHESIA 26
880 HYPERPYREXIA 26
881 IRON DEFICIENCY 26
882 LUNG INFECTION 26
883 MUSCLE TWITCHING 26
884 NASAL DISCOMFORT 26
885 NEEDLE ISSUE 26
886 ONYCHOMADESIS 26
887 PANCREATITIS 26
888 PLEURAL DISORDER 26
889 PRODUCT DISTRIBUTION ISSUE 26
890 QUALITY OF LIFE DECREASED 26
891 RENAL FAILURE ACUTE 26
892 SLUGGISHNESS 26
893 THROMBOPHLEBITIS 26
894 TRIGGER FINGER 26
895 UROSEPSIS 26
896 VASODILATATION 26
897 VENTRICULAR EXTRASYSTOLES 26
898 ACCIDENTAL OVERDOSE 25
899 ACUTE MYELOID LEUKAEMIA 25
900 ADVERSE REACTION 25
901 BASOPHIL COUNT INCREASED 25
902 BEDRIDDEN 25
903 BLOOD ALKALINE PHOSPHATASE ABNORMAL 25
904 COLON CANCER 25
905 CORONAVIRUS INFECTION 25
906 ENCEPHALOPATHY 25
907 METABOLIC DISORDER 25
908 NECK MASS 25
909 OBSTRUCTIVE AIRWAYS DISORDER 25
910 OCULAR ICTERUS 25
911 OESOPHAGEAL STENOSIS 25
912 OESTRADIOL INCREASED 25
913 PERFORMANCE STATUS DECREASED 25
914 PERIODONTAL DISEASE 25
915 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 25
916 PROTEINURIA 25
917 RED BLOOD CELL COUNT ABNORMAL 25
918 TEMPERATURE INTOLERANCE 25
919 ANGER 24
920 BASAL CELL CARCINOMA 24
921 BUNDLE BRANCH BLOCK LEFT 24
922 COVID-19 PNEUMONIA 24
923 DISABILITY 24
924 EAR INFECTION 24
925 ENDOCARDITIS 24
926 ENTEROCOLITIS 24
927 FACET JOINT SYNDROME 24
928 FOOD POISONING 24
929 GAMMA-GLUTAMYLTRANSFERASE DECREASED 24
930 GENERALISED OEDEMA 24
931 HAEMOLYTIC ANAEMIA 24
932 INFUSION SITE COLDNESS 24
933 JAW FRACTURE 24
934 JOINT DISLOCATION 24
935 LEUKOCYTOSIS 24
936 LYMPHADENITIS 24
937 MELAENA 24
938 METASTASES TO STOMACH 24
939 NAIL DISCOLOURATION 24
940 PNEUMONIA ASPIRATION 24
941 POST-TRAUMATIC NECK SYNDROME 24
942 SHOCK 24
943 SKIN ODOUR ABNORMAL 24
944 SPONDYLOLISTHESIS 24
945 SYRINGE ISSUE 24
946 THORACIC VERTEBRAL FRACTURE 24
947 THYROID MASS 24
948 ACUTE RESPIRATORY DISTRESS SYNDROME 23
949 CARDIAC MURMUR 23
950 CEREBRAL THROMBOSIS 23
951 COLD SWEAT 23
952 ELECTROCARDIOGRAM ABNORMAL 23
953 FOOD INTOLERANCE 23
954 INFUSION SITE HAEMORRHAGE 23
955 INFUSION SITE INDURATION 23
956 INJECTION SITE EXTRAVASATION 23
957 LUNG OPACITY 23
958 MENINGOENCEPHALITIS HERPETIC 23
959 NERVE COMPRESSION 23
960 OVARIAN DISORDER 23
961 PNEUMONIA BACTERIAL 23
962 POST PROCEDURAL COMPLICATION 23
963 RESPIRATORY TRACT CONGESTION 23
964 SARS-COV-2 TEST POSITIVE 23
965 THERMAL BURN 23
966 VASCULAR CALCIFICATION 23
967 ACCIDENT 22
968 BLADDER CANCER 22
969 EYE DISCHARGE 22
970 EYE INFLAMMATION 22
971 FEELING OF DESPAIR 22
972 HYPERTHYROIDISM 22
973 INJECTION SITE HAEMATOMA 22
974 INTERVERTEBRAL DISC DISORDER 22
975 KYPHOSIS 22
976 LYMPHOCYTE COUNT INCREASED 22
977 METASTASES TO NECK 22
978 MUSCULOSKELETAL DISORDER 22
979 MUSCULOSKELETAL TOXICITY 22
980 OESOPHAGEAL PAIN 22
981 PERIARTHRITIS 22
982 PERITONITIS 22
983 PHYSICAL DISABILITY 22
984 PLATELET DISORDER 22
985 POISONING 22
986 PRODUCT ADMINISTRATION ERROR 22
987 PULMONARY PAIN 22
988 RECTAL CANCER 22
989 RENAL TUBULAR NECROSIS 22
990 SINUS BRADYCARDIA 22
991 THINKING ABNORMAL 22
992 THYROID NEOPLASM 22
993 TONGUE ULCERATION 22
994 TREATMENT NONCOMPLIANCE 22
995 TRIGEMINAL NEURALGIA 22
996 ABSCESS JAW 21
997 ACUTE LYMPHOCYTIC LEUKAEMIA 21
998 APATHY 21
999 BACK INJURY 21